{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/18/3314541/0/en/Teva-Submits-NDA-for-Ecopipam-a-First-in-Class-Investigational-Therapy-for-Pediatric-Tourette-Syndrome.html", "message": "News view counter 807955 successfully enlarged"}